Global Amlodipine Besylate Market Insights, Forecast to 2029

Publisher Name :
Date: 28-Mar-2023
No. of pages: 125
Inquire Before Buying

This report presents an overview of global market for Amlodipine Besylate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Amlodipine Besylate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Amlodipine Besylate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amlodipine Besylate sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Amlodipine Besylate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Amlodipine Besylate sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma and Upsher-Smith Laboratories, etc.

By Company

- Pfizer

- Mylan

- Dr. Reddy's Laboratories

- Apotex

- Teva Pharmaceutical

- Cipla

- Hikma Pharmaceuticals

- Strides Pharma

- Upsher-Smith Laboratories

- InvaGen Pharmaceuticals

- Sun Pharmaceutical

- Aurobindo Pharma

- Lupin Pharmaceuticals

- Zydus Pharmaceuticals

- Oxford Pharm

- Wockhardt

- Epic Pharma

- CR Pharmaceutical

- Alkem Laboratories

- MACLEODS

Segment by Type

- 2.5mg Tablets

- 5mg Tablets

- 10mg Tablets

Segment by Application

- High Blood Pressure

- Heart Disease

Segment by Region

- US & Canada

- - U.S.

- - Canada

- China

- Asia (excluding China)

- - Japan

- - South Korea

- - China Taiwan

- Southeast Asia

- - India

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Middle East, Africa, Latin America

- - Brazil

- - Mexico

- - Turkey

- - Israel

- - GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Amlodipine Besylate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Amlodipine Besylate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amlodipine Besylate sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Amlodipine Besylate Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Amlodipine Besylate Product Introduction
1.2 Market by Type
1.2.1 Global Amlodipine Besylate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 2.5mg Tablets
1.2.3 5mg Tablets
1.2.4 10mg Tablets
1.3 Market by Application
1.3.1 Global Amlodipine Besylate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 High Blood Pressure
1.3.3 Heart Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Amlodipine Besylate Sales Estimates and Forecasts 2018-2029
2.2 Global Amlodipine Besylate Revenue by Region
2.2.1 Global Amlodipine Besylate Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Amlodipine Besylate Revenue by Region (2018-2023)
2.2.3 Global Amlodipine Besylate Revenue by Region (2024-2029)
2.2.4 Global Amlodipine Besylate Revenue Market Share by Region (2018-2029)
2.3 Global Amlodipine Besylate Sales Estimates and Forecasts 2018-2029
2.4 Global Amlodipine Besylate Sales by Region
2.4.1 Global Amlodipine Besylate Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Amlodipine Besylate Sales by Region (2018-2023)
2.4.3 Global Amlodipine Besylate Sales by Region (2024-2029)
2.4.4 Global Amlodipine Besylate Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Amlodipine Besylate Sales by Manufacturers
3.1.1 Global Amlodipine Besylate Sales by Manufacturers (2018-2023)
3.1.2 Global Amlodipine Besylate Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Amlodipine Besylate in 2022
3.2 Global Amlodipine Besylate Revenue by Manufacturers
3.2.1 Global Amlodipine Besylate Revenue by Manufacturers (2018-2023)
3.2.2 Global Amlodipine Besylate Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Amlodipine Besylate Revenue in 2022
3.3 Global Key Players of Amlodipine Besylate, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Amlodipine Besylate Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Amlodipine Besylate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Amlodipine Besylate, Product Offered and Application
3.8 Global Key Manufacturers of Amlodipine Besylate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Amlodipine Besylate Sales by Type
4.1.1 Global Amlodipine Besylate Historical Sales by Type (2018-2023)
4.1.2 Global Amlodipine Besylate Forecasted Sales by Type (2024-2029)
4.1.3 Global Amlodipine Besylate Sales Market Share by Type (2018-2029)
4.2 Global Amlodipine Besylate Revenue by Type
4.2.1 Global Amlodipine Besylate Historical Revenue by Type (2018-2023)
4.2.2 Global Amlodipine Besylate Forecasted Revenue by Type (2024-2029)
4.2.3 Global Amlodipine Besylate Revenue Market Share by Type (2018-2029)
4.3 Global Amlodipine Besylate Price by Type
4.3.1 Global Amlodipine Besylate Price by Type (2018-2023)
4.3.2 Global Amlodipine Besylate Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Amlodipine Besylate Sales by Application
5.1.1 Global Amlodipine Besylate Historical Sales by Application (2018-2023)
5.1.2 Global Amlodipine Besylate Forecasted Sales by Application (2024-2029)
5.1.3 Global Amlodipine Besylate Sales Market Share by Application (2018-2029)
5.2 Global Amlodipine Besylate Revenue by Application
5.2.1 Global Amlodipine Besylate Historical Revenue by Application (2018-2023)
5.2.2 Global Amlodipine Besylate Forecasted Revenue by Application (2024-2029)
5.2.3 Global Amlodipine Besylate Revenue Market Share by Application (2018-2029)
5.3 Global Amlodipine Besylate Price by Application
5.3.1 Global Amlodipine Besylate Price by Application (2018-2023)
5.3.2 Global Amlodipine Besylate Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Amlodipine Besylate Market Size by Type
6.1.1 US & Canada Amlodipine Besylate Sales by Type (2018-2029)
6.1.2 US & Canada Amlodipine Besylate Revenue by Type (2018-2029)
6.2 US & Canada Amlodipine Besylate Market Size by Application
6.2.1 US & Canada Amlodipine Besylate Sales by Application (2018-2029)
6.2.2 US & Canada Amlodipine Besylate Revenue by Application (2018-2029)
6.3 US & Canada Amlodipine Besylate Market Size by Country
6.3.1 US & Canada Amlodipine Besylate Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Amlodipine Besylate Sales by Country (2018-2029)
6.3.3 US & Canada Amlodipine Besylate Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Amlodipine Besylate Market Size by Type
7.1.1 Europe Amlodipine Besylate Sales by Type (2018-2029)
7.1.2 Europe Amlodipine Besylate Revenue by Type (2018-2029)
7.2 Europe Amlodipine Besylate Market Size by Application
7.2.1 Europe Amlodipine Besylate Sales by Application (2018-2029)
7.2.2 Europe Amlodipine Besylate Revenue by Application (2018-2029)
7.3 Europe Amlodipine Besylate Market Size by Country
7.3.1 Europe Amlodipine Besylate Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Amlodipine Besylate Sales by Country (2018-2029)
7.3.3 Europe Amlodipine Besylate Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Amlodipine Besylate Market Size
8.1.1 China Amlodipine Besylate Sales (2018-2029)
8.1.2 China Amlodipine Besylate Revenue (2018-2029)
8.2 China Amlodipine Besylate Market Size by Application
8.2.1 China Amlodipine Besylate Sales by Application (2018-2029)
8.2.2 China Amlodipine Besylate Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Amlodipine Besylate Market Size by Type
9.1.1 Asia Amlodipine Besylate Sales by Type (2018-2029)
9.1.2 Asia Amlodipine Besylate Revenue by Type (2018-2029)
9.2 Asia Amlodipine Besylate Market Size by Application
9.2.1 Asia Amlodipine Besylate Sales by Application (2018-2029)
9.2.2 Asia Amlodipine Besylate Revenue by Application (2018-2029)
9.3 Asia Amlodipine Besylate Sales by Region
9.3.1 Asia Amlodipine Besylate Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Amlodipine Besylate Revenue by Region (2018-2029)
9.3.3 Asia Amlodipine Besylate Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Amlodipine Besylate Market Size by Type
10.1.1 Middle East, Africa and Latin America Amlodipine Besylate Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Amlodipine Besylate Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Amlodipine Besylate Market Size by Application
10.2.1 Middle East, Africa and Latin America Amlodipine Besylate Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Amlodipine Besylate Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Amlodipine Besylate Sales by Country
10.3.1 Middle East, Africa and Latin America Amlodipine Besylate Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Amlodipine Besylate Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Amlodipine Besylate Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Pfizer Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Overview
11.2.3 Mylan Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Mylan Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Information
11.3.2 Dr. Reddy's Laboratories Overview
11.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dr. Reddy's Laboratories Recent Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Overview
11.4.3 Apotex Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Apotex Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Recent Developments
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Information
11.5.2 Teva Pharmaceutical Overview
11.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Teva Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Pharmaceutical Recent Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Overview
11.6.3 Cipla Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Cipla Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Recent Developments
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Information
11.7.2 Hikma Pharmaceuticals Overview
11.7.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Hikma Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hikma Pharmaceuticals Recent Developments
11.8 Strides Pharma
11.8.1 Strides Pharma Company Information
11.8.2 Strides Pharma Overview
11.8.3 Strides Pharma Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Strides Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Strides Pharma Recent Developments
11.9 Upsher-Smith Laboratories
11.9.1 Upsher-Smith Laboratories Company Information
11.9.2 Upsher-Smith Laboratories Overview
11.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Upsher-Smith Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Upsher-Smith Laboratories Recent Developments
11.10 InvaGen Pharmaceuticals
11.10.1 InvaGen Pharmaceuticals Company Information
11.10.2 InvaGen Pharmaceuticals Overview
11.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 InvaGen Pharmaceuticals Recent Developments
11.11 Sun Pharmaceutical
11.11.1 Sun Pharmaceutical Company Information
11.11.2 Sun Pharmaceutical Overview
11.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Sun Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sun Pharmaceutical Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Information
11.12.2 Aurobindo Pharma Overview
11.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Aurobindo Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aurobindo Pharma Recent Developments
11.13 Lupin Pharmaceuticals
11.13.1 Lupin Pharmaceuticals Company Information
11.13.2 Lupin Pharmaceuticals Overview
11.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Lupin Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Lupin Pharmaceuticals Recent Developments
11.14 Zydus Pharmaceuticals
11.14.1 Zydus Pharmaceuticals Company Information
11.14.2 Zydus Pharmaceuticals Overview
11.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Zydus Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Zydus Pharmaceuticals Recent Developments
11.15 Oxford Pharm
11.15.1 Oxford Pharm Company Information
11.15.2 Oxford Pharm Overview
11.15.3 Oxford Pharm Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Oxford Pharm Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Oxford Pharm Recent Developments
11.16 Wockhardt
11.16.1 Wockhardt Company Information
11.16.2 Wockhardt Overview
11.16.3 Wockhardt Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Wockhardt Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Wockhardt Recent Developments
11.17 Epic Pharma
11.17.1 Epic Pharma Company Information
11.17.2 Epic Pharma Overview
11.17.3 Epic Pharma Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Epic Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Epic Pharma Recent Developments
11.18 CR Pharmaceutical
11.18.1 CR Pharmaceutical Company Information
11.18.2 CR Pharmaceutical Overview
11.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 CR Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 CR Pharmaceutical Recent Developments
11.19 Alkem Laboratories
11.19.1 Alkem Laboratories Company Information
11.19.2 Alkem Laboratories Overview
11.19.3 Alkem Laboratories Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.19.4 Alkem Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Alkem Laboratories Recent Developments
11.20 MACLEODS
11.20.1 MACLEODS Company Information
11.20.2 MACLEODS Overview
11.20.3 MACLEODS Amlodipine Besylate Sales, Price, Revenue and Gross Margin (2018-2023)
11.20.4 MACLEODS Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 MACLEODS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Amlodipine Besylate Industry Chain Analysis
12.2 Amlodipine Besylate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Amlodipine Besylate Production Mode & Process
12.4 Amlodipine Besylate Sales and Marketing
12.4.1 Amlodipine Besylate Sales Channels
12.4.2 Amlodipine Besylate Distributors
12.5 Amlodipine Besylate Customers
13 Market Dynamics
13.1 Amlodipine Besylate Industry Trends
13.2 Amlodipine Besylate Market Drivers
13.3 Amlodipine Besylate Market Challenges
13.4 Amlodipine Besylate Market Restraints
14 Key Findings in The Global Amlodipine Besylate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Amlodipine Besylate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 2.5mg Tablets
Table 3. Major Manufacturers of 5mg Tablets
Table 4. Major Manufacturers of 10mg Tablets
Table 5. Global Amlodipine Besylate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Amlodipine Besylate Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Amlodipine Besylate Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Amlodipine Besylate Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Amlodipine Besylate Revenue Market Share by Region (2018-2023)
Table 10. Global Amlodipine Besylate Revenue Market Share by Region (2024-2029)
Table 11. Global Amlodipine Besylate Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Amlodipine Besylate Sales by Region (2018-2023) & (K Units)
Table 13. Global Amlodipine Besylate Sales by Region (2024-2029) & (K Units)
Table 14. Global Amlodipine Besylate Sales Market Share by Region (2018-2023)
Table 15. Global Amlodipine Besylate Sales Market Share by Region (2024-2029)
Table 16. Global Amlodipine Besylate Sales by Manufacturers (2018-2023) & (K Units)
Table 17. Global Amlodipine Besylate Sales Share by Manufacturers (2018-2023)
Table 18. Global Amlodipine Besylate Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Amlodipine Besylate Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Amlodipine Besylate, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Amlodipine Besylate Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Amlodipine Besylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Amlodipine Besylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2022)
Table 24. Global Key Manufacturers of Amlodipine Besylate, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Amlodipine Besylate, Product Offered and Application
Table 26. Global Key Manufacturers of Amlodipine Besylate, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Amlodipine Besylate Sales by Type (2018-2023) & (K Units)
Table 29. Global Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 30. Global Amlodipine Besylate Sales Share by Type (2018-2023)
Table 31. Global Amlodipine Besylate Sales Share by Type (2024-2029)
Table 32. Global Amlodipine Besylate Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Amlodipine Besylate Revenue Share by Type (2018-2023)
Table 35. Global Amlodipine Besylate Revenue Share by Type (2024-2029)
Table 36. Amlodipine Besylate Price by Type (2018-2023) & (USD/Unit)
Table 37. Global Amlodipine Besylate Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Amlodipine Besylate Sales by Application (2018-2023) & (K Units)
Table 39. Global Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 40. Global Amlodipine Besylate Sales Share by Application (2018-2023)
Table 41. Global Amlodipine Besylate Sales Share by Application (2024-2029)
Table 42. Global Amlodipine Besylate Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Amlodipine Besylate Revenue Share by Application (2018-2023)
Table 45. Global Amlodipine Besylate Revenue Share by Application (2024-2029)
Table 46. Amlodipine Besylate Price by Application (2018-2023) & (USD/Unit)
Table 47. Global Amlodipine Besylate Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Amlodipine Besylate Sales by Type (2018-2023) & (K Units)
Table 49. US & Canada Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Amlodipine Besylate Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Amlodipine Besylate Sales by Application (2018-2023) & (K Units)
Table 53. US & Canada Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Amlodipine Besylate Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Amlodipine Besylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Amlodipine Besylate Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Amlodipine Besylate Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Amlodipine Besylate Sales by Country (2018-2023) & (K Units)
Table 60. US & Canada Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 61. Europe Amlodipine Besylate Sales by Type (2018-2023) & (K Units)
Table 62. Europe Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 63. Europe Amlodipine Besylate Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Amlodipine Besylate Sales by Application (2018-2023) & (K Units)
Table 66. Europe Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 67. Europe Amlodipine Besylate Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Amlodipine Besylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Amlodipine Besylate Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Amlodipine Besylate Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Amlodipine Besylate Sales by Country (2018-2023) & (K Units)
Table 73. Europe Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 74. China Amlodipine Besylate Sales by Type (2018-2023) & (K Units)
Table 75. China Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 76. China Amlodipine Besylate Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Amlodipine Besylate Sales by Application (2018-2023) & (K Units)
Table 79. China Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 80. China Amlodipine Besylate Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Amlodipine Besylate Sales by Type (2018-2023) & (K Units)
Table 83. Asia Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 84. Asia Amlodipine Besylate Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Amlodipine Besylate Sales by Application (2018-2023) & (K Units)
Table 87. Asia Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 88. Asia Amlodipine Besylate Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Amlodipine Besylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Amlodipine Besylate Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Amlodipine Besylate Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Amlodipine Besylate Sales by Region (2018-2023) & (K Units)
Table 94. Asia Amlodipine Besylate Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Amlodipine Besylate Sales by Type (2018-2023) & (K Units)
Table 96. Middle East, Africa and Latin America Amlodipine Besylate Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Amlodipine Besylate Sales by Application (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America Amlodipine Besylate Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Amlodipine Besylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Amlodipine Besylate Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Amlodipine Besylate Sales by Country (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Amlodipine Besylate Sales by Country (2024-2029) & (K Units)
Table 108. Pfizer Company Information
Table 109. Pfizer Description and Major Businesses
Table 110. Pfizer Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Pfizer Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Pfizer Recent Developments
Table 113. Mylan Company Information
Table 114. Mylan Description and Major Businesses
Table 115. Mylan Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Mylan Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Mylan Recent Developments
Table 118. Dr. Reddy's Laboratories Company Information
Table 119. Dr. Reddy's Laboratories Description and Major Businesses
Table 120. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Dr. Reddy's Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Dr. Reddy's Laboratories Recent Developments
Table 123. Apotex Company Information
Table 124. Apotex Description and Major Businesses
Table 125. Apotex Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Apotex Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Apotex Recent Developments
Table 128. Teva Pharmaceutical Company Information
Table 129. Teva Pharmaceutical Description and Major Businesses
Table 130. Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Teva Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Teva Pharmaceutical Recent Developments
Table 133. Cipla Company Information
Table 134. Cipla Description and Major Businesses
Table 135. Cipla Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Cipla Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Cipla Recent Developments
Table 138. Hikma Pharmaceuticals Company Information
Table 139. Hikma Pharmaceuticals Description and Major Businesses
Table 140. Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Hikma Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Hikma Pharmaceuticals Recent Developments
Table 143. Strides Pharma Company Information
Table 144. Strides Pharma Description and Major Businesses
Table 145. Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. Strides Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Strides Pharma Recent Developments
Table 148. Upsher-Smith Laboratories Company Information
Table 149. Upsher-Smith Laboratories Description and Major Businesses
Table 150. Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. Upsher-Smith Laboratories Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Upsher-Smith Laboratories Recent Developments
Table 153. InvaGen Pharmaceuticals Company Information
Table 154. InvaGen Pharmaceuticals Description and Major Businesses
Table 155. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 156. InvaGen Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. InvaGen Pharmaceuticals Recent Developments
Table 158. Sun Pharmaceutical Company Information
Table 159. Sun Pharmaceutical Description and Major Businesses
Table 160. Sun Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 161. Sun Pharmaceutical Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Sun Pharmaceutical Recent Developments
Table 163. Aurobindo Pharma Company Information
Table 164. Aurobindo Pharma Description and Major Businesses
Table 165. Aurobindo Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 166. Aurobindo Pharma Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Aurobindo Pharma Recent Developments
Table 168. Lupin Pharmaceuticals Company Information
Table 169. Lupin Pharmaceuticals Description and Major Businesses
Table 170. Lupin Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 171. Lupin Pharmaceuticals Amlodipine Besylate Product Model Numbers, Pictures, Descriptions and Specificati
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs